Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1981-01-21
1983-06-07
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
548183, C07D27704, A61K 31425
Patent
active
043871011
ABSTRACT:
A thiazolidine derivatives of the formula: ##STR1## wherein R is a phenyl group having 2 nuclear substituent groups selected from the group consisting of a lower alkyl having 1 to 6 carbon atoms, a lower alkoxy having 1 to 7 carbon atoms, hydroxyl and a carboxylic acyloxy having 1 to 4 carbon atoms, or a phenyl group having a methylenedioxy group in adjacent positions on its ring; R.sup.1 is H or an alkyl having 1 to 6 carbon atoms, or a physiologically acceptable salt thereof is a novel compound having the activity to control certain chronic symptoms due to diabetes, such as diabetic cataract, diabetic neuropathy and diabetic retinosis.
REFERENCES:
patent: 2678318 (1952-10-01), Heilbron et al.
patent: 3311655 (1967-03-01), Boileau et al.
patent: 3825553 (1974-07-01), Diamond et al.
patent: 4186129 (1980-01-01), Huth et al.
patent: 4340605 (1982-07-01), Kawamatsu et al.
patent: 4349683 (1982-09-01), Bigg
Burton et al., Jour. of Medicinal Chemistry, vol. 13, pp. 1009-1012, (1970).
Kawamatsu Yutaka
Yamamoto Yujiro
Rizzo Nicholas S.
Senju Pharmaceutical Co. Ltd.
Takeda Chemical Industries Ltd.
LandOfFree
Thiazolidine derivatives and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazolidine derivatives and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolidine derivatives and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2342969